PHARMING GRP SP. ADRS

Historical 13F Holders

Symbol
PHAR
CUSIP
71716E105
All holders as of
Q2 2026
Type
Equity
Class
SPON ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 71716E105 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Morgan Stanley 13G/A 1.2% 4/7/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 48.3 k $482 k
2026 Q2 16 95.2 k $1.31 M
2026 Q1 13 85.8 k $1.43 M
2025 Q4 11 140 k $2.48 M
2025 Q3 9 59.1 k $857 k
2025 Q2 5 58.9 k $630 k
2025 Q1 5 51.9 k $434 k
2024 Q4 6 51.1 k $514 k
2024 Q3 5 44.7 k $369 k
2024 Q2 6 30.4 k $254 k
2024 Q1 6 26.2 k $275 k
2023 Q4 4 23.3 k $266 k
2023 Q3 4 25.9 k $296 k
2023 Q2 3 25.0 k $291 k
2023 Q1 4 25.8 k $296 k
2022 Q4 4 29.5 k $325 k
2022 Q3 4 25.0 k $245 k
2022 Q2 4 20.5 k $180 k
2022 Q1 5 20.6 k $184 k
2021 Q4 4 18.6 k $166 k
2021 Q3 5 26.4 k $249 k
2021 Q2 8 198 k $2.24 M
2021 Q1 4 192 k $2.47 M
2020 Q4 3 1.90 M $2.96 M
2020 Q2 1 16.5 k $145 k